Skip to main content
. 2020 Oct 1;4(19):4669–4678. doi: 10.1182/bloodadvances.2020002118

Table 5.

Outcomes by treatment cohort and number of prior lines of therapy

Outcomes Alternate CAR T P
2 prior lines
 Total, n 146 32
 CR rate, % 22 56 <.001
 ORR, % 32 75 <.001
 Median OS, mo 6.5 19.3 .02
 Median PFS, mo 2.3 6.4 .04
3 prior lines
 Total, n 59 23
 CR rate, % 8.6 52 <.001
 ORR, % 16 74 <.001
 Median OS, mo 4.7 Not reached .001
 Median PFS, mo 1.7 12.3 <.001
4 prior lines
 Total, n 26 14
 CR rate, % 8 43 .02
 ORR, % 8 64 <.001
 Median OS, mo 2.9 7.0 .03
 Median PFS, mo 1.4 3.0 .008

P values in bold are statistically significant.